ID

43337

Beschreibung

ODM derived from http://clinicaltrials.gov/show/NCT00312845

Link

http://clinicaltrials.gov/show/NCT00312845

Stichworte

  1. 16.03.12 16.03.12 -
  2. 14.04.14 14.04.14 - Julian Varghese
  3. 20.09.21 20.09.21 -
Hochgeladen am

20. September 2021

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility NCT00312845 Non-Hodgkin's Lymphoma

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Einschlusskriterien
Beschreibung

Einschlusskriterien

Alter >= 18 Jahre
Beschreibung

Age

Datentyp

boolean

Diagnosis of follicular B-NHL of the following subtypes (World Health Organization [WHO] classification 1997): follicular lymphoma (FL) (Grades 1 and 2).
Beschreibung

follicular B-NHL, subtypes follicular lymphoma (FL) (Grades 1 and 2

Datentyp

boolean

Documented relapse or progression following prior antineoplastic treatment. New lesions or objective evidence of progression of existing lesions must document relapse or progression following the previous therapy.
Beschreibung

relapse or progression following prior anti-neoplastic treatment

Datentyp

boolean

If any prior regimen included rituximab, the subject must have responded (complete response [CR], unconfirmed complete response [CRu], partial response [PR]), and the time to progression (TTP) from the first dose of rituximab must have been 6 months or more.
Beschreibung

If any prior regimen included rituximab, the subject must have responded.

Datentyp

boolean

At least 1 measurable tumor mass (greater than 1.5 cm in the longest dimension and greater than 1.0 cm in the short axis) that has not been previously irradiated, or has grown since previous irradiation
Beschreibung

At least 1 measurable tumor mass

Datentyp

boolean

In the opinion of the investigator the decision to initiate treatment is justified to manage the subject's lymphoma
Beschreibung

the decision to initiate treatment is justified to manage the subject's lymphoma

Datentyp

boolean

No active central nervous system lymphoma
Beschreibung

No active central nervous system lymphoma

Datentyp

boolean

Eastern Cooperative Oncology Group [ECOG] status ? 2
Beschreibung

ECOG status ? 2

Datentyp

boolean

Female subjects must be postmenopausal (for at least 6 months), surgically sterile, abstinent, or, if sexually active, be practicing an effective method of birth control (e.g., prescription oral contraceptives, contraceptive injections, intrauterine device, double-barrier method, contraceptive patch, male partner sterilization) before entry and throughout the study; and have a negative serum beta-human chorionic gonadotropin (?-hCG) pregnancy test at screening.
Beschreibung

Female subjects must be postmenopausal, surgically sterile, abstinent, or, if sexually active, be practicing an effective method of birth control; and have a negative pregnancy test at screening.

Datentyp

boolean

Subjects (or their legally acceptable representatives) must have signed an informed consent document indicating that they understand the purpose of and procedures required for the study and are willing to participate in the study.
Beschreibung

informed consent

Datentyp

boolean

In countries where health authorities have approved the pharmacogenomic testing, subjects or their legally acceptable representatives must have signed a separate informed consent that they agree to participate in the genetic part and protein testing part of the study; participation in the genetic and protein testing component is mandatory for pharmacogenomics testing, but optional for serum protein testing and future testing.
Beschreibung

If health authorities have approved the pharmacogenomic testing, subjects must have signed a separate informed consent.

Datentyp

boolean

Ausschlusskriterien
Beschreibung

Ausschlusskriterien

Diagnosed or treated for a malignancy other than NHL within 1 year of randomization, or who were previously diagnosed with a malignancy other than NHL and have any radiographic or biochemical marker evidence of malignancy. Subjects with completely resected basal cell carcinoma, squamous cell carcinoma of the skin, or in situ malignancy are not excluded.
Beschreibung

malignancy other than NHL

Datentyp

boolean

Clinical evidence of a transformation from indolent NHL to a more aggressive form of NHL.
Beschreibung

transformation from indolent NHL to a more aggressive form of NHL

Datentyp

boolean

Prior treatment with VELCADE; Antineoplastic (including unconjugated therapeutic antibodies), experimental, or radiation therapy within 3 weeks before randomization; Nitrosoureas within 6 weeks before randomization; Radioimmunoconjugates or toxin immunoconjugates within 10 weeks before randomization; Stem cell transplant within 6 months before randomization; Major surgery within 2 weeks before randomization.
Beschreibung

disallowed therapies

Datentyp

boolean

Residual toxic effects of previous therapy or surgery of Grade 3 or worse
Beschreibung

Residual toxic effects of previous therapy or surgery

Datentyp

boolean

Peripheral neuropathy or neuropathic pain of Grade 2 or worse
Beschreibung

Peripheral neuropathy or neuropathic pain

Datentyp

boolean

Have received an experimental drug or used an experimental medical device within 21 days before the planned start of treatment.
Beschreibung

Have received an experimental drug or used an experimental medical device.

Datentyp

boolean

History of allergic reaction attributable to compounds containing boron or mannitol
Beschreibung

allergic reaction attributable to compounds containing boron or mannitol

Datentyp

boolean

Known anaphylaxis or immunoglobulin E (IgE)-mediated hypersensitivity to murine proteins or to any component of rituximab including polysorbate 80 and sodium citrate dihydrate
Beschreibung

hypersensitivity to murine proteins or to any component of rituximab

Datentyp

boolean

Concurrent treatment with another investigational agent
Beschreibung

treatment with another investigational agent

Datentyp

boolean

Female subject who is pregnant or breast-feeding
Beschreibung

Female subject is pregnant or breast-feeding

Datentyp

boolean

Medizinische Konzepte
Beschreibung

Medizinische Konzepte

Alter
Beschreibung

Age

Datentyp

string

Alias
UMLS CUI
C0001779
SNOMED CT 2010_0731
397669002
Diagnose
Beschreibung

Diagnosis

Datentyp

string

Alias
UMLS CUI
C0011900
SNOMED CT 2010_0731
439401001
LOINC Version 232
MTHU008876
Mann
Beschreibung

man

Datentyp

string

Alias
UMLS CUI
C0025266
SNOMED CT 2010_0731
339947000
Frau
Beschreibung

Woman

Datentyp

string

Alias
UMLS CUI
C0043210
SNOMED CT 2010_0731
224526002
Lymphoma, Non-Hodgkin (Non-Hodgkins lymphoma)
Beschreibung

NHL

Datentyp

string

Alias
UMLS CUI
C0024305
SNOMED CT 2010_0731
118601006
MedDRA 13.1
10029547
ICD-10-CM Version 2010
C85.9
Follicular low grade B-cell lymphoma, Follicular non-Hodgkin lymphoma
Beschreibung

Lymphoma, Follicular

Datentyp

string

Alias
UMLS CUI
C0024301
SNOMED CT 2010_0731
277618009, 308121000
MedDRA 13.1
10061170
ICD-10-CM Version 2010
C82
ICD-9-CM Version 2011
202.0
Follicular lymphoma grade I, unspecified site
Beschreibung

FL grade I

Datentyp

string

Alias
UMLS CUI
C2853785
ICD-10-CM Version 2010
C82.00
Follicular lymphoma grade II, unspecified site
Beschreibung

FL grade II

Datentyp

string

Alias
UMLS CUI
C2853795
ICD-10-CM Version 2010
C82.10
WHO-Klassifikation
Beschreibung

WHO classification

Datentyp

string

Alias
UMLS CUI
C0451584
SNOMED CT 2010_0731
273931002
Rezidiv
Beschreibung

Relapse

Datentyp

string

Alias
UMLS CUI
C0277556
SNOMED CT 2010_0731
58184002
Documented (qualifier value)
Beschreibung

Documented

Datentyp

string

Alias
UMLS CUI
C1301725
SNOMED CT 2010_0731
397934002
Krankheitsverlauf
Beschreibung

Progression

Datentyp

string

Alias
UMLS CUI
C0242656
SNOMED CT 2010_0731
246453008
MedDRA 13.1
10061818
Antineoplastic Drug/Agent Therapy
Beschreibung

Antineoplastic Drug/Agent Therapy

Datentyp

string

Alias
UMLS CUI
CL378288
Therapie
Beschreibung

Therapy

Datentyp

string

Alias
UMLS CUI
C0087111
Previous (qualifier value)
Beschreibung

Previous

Datentyp

string

Alias
UMLS CUI
C0205156
SNOMED CT 2010_0731
9130008
Läsion
Beschreibung

Lesion

Datentyp

string

Alias
UMLS CUI
C0221198
SNOMED CT 2010_0731
49755003
Evidence of
Beschreibung

Evidence

Datentyp

string

Alias
UMLS CUI
C0332120
SNOMED CT 2010_0731
18669006
Treatment Regimen
Beschreibung

Regimen

Datentyp

string

Alias
UMLS CUI
CL031856
Rituximab
Beschreibung

Rituxan

Datentyp

string

Alias
UMLS CUI
C0732355
SNOMED CT 2010_0731
386919002
Complete Response (CR)
Beschreibung

In complete remission

Datentyp

string

Alias
UMLS CUI
C0677874
SNOMED CT 2010_0731
103338009
partial response (partial remission)
Beschreibung

PR

Datentyp

string

Alias
UMLS CUI
C1521726
SNOMED CT 2010_0731
103337004
Time to Progression
Beschreibung

TTP

Datentyp

string

Alias
UMLS CUI
CL425094
Mass of body structure, Mass (morphologic abnormality), Tumor Mass
Beschreibung

Mass

Datentyp

string

Alias
UMLS CUI
C0577559
SNOMED CT 2010_0731
4147007
MedDRA 13.1
10026865
Irradiation
Beschreibung

Irradiation

Datentyp

string

Alias
UMLS CUI
C1522449
SNOMED CT 2010_0731
108290001
MedDRA 13.1
10037794
Lymphom
Beschreibung

Lymphoma

Datentyp

string

Alias
UMLS CUI
C0024299
SNOMED CT 2010_0731
21964009
MedDRA 13.1
10025310
ICD-10-CM Version 2010
C85.9
Central Nervous System Lymphoma
Beschreibung

CNS Lymphoma

Datentyp

string

Alias
UMLS CUI
C0280803
SNOMED CT 2010_0731
307649006
MedDRA 13.1
10007953
ICD-9-CM Version 2011
200.5
aktiv
Beschreibung

Active

Datentyp

string

Alias
UMLS CUI
C0205177
SNOMED CT 2010_0731
55561003
ECOG Status
Beschreibung

ECOG

Datentyp

string

Alias
UMLS CUI
C1520224
SNOMED CT 2010_0731
424122007
weiblich
Beschreibung

female

Datentyp

string

Alias
UMLS CUI
C0086287
SNOMED CT 2010_0731
248152002
HL7 V3 02-34
F
Postmenopause
Beschreibung

Postmenopause

Datentyp

string

Alias
UMLS CUI
C0206159
MedDRA 13.1
10051775
Operative Surgical Procedures
Beschreibung

Surgical

Datentyp

string

Alias
UMLS CUI
C0543467
SNOMED CT 2010_0731
83578000
MedDRA 13.1
10051332
LOINC Version 232
MTHU000079
Steril
Beschreibung

Sterile

Datentyp

string

Alias
UMLS CUI
C0232920
SNOMED CT 2010_0731
261029002
Abstinent
Beschreibung

Abstinent

Datentyp

string

Alias
UMLS CUI
C0457801
SNOMED CT 2010_0731
105542008
MedDRA 13.1
10043185
Kontrazeption
Beschreibung

Contraception

Datentyp

string

Alias
UMLS CUI
C0700589
SNOMED CT 2010_0731
146680009
MedDRA 13.1
10010808
orales Kontrazeptivum
Beschreibung

Contraceptives, Oral

Datentyp

string

Alias
UMLS CUI
C0009905
SNOMED CT 2010_0731
59261009
Prescription (procedure)
Beschreibung

Prescriptions

Datentyp

string

Alias
UMLS CUI
C0033080
SNOMED CT 2010_0731
16076005
Kontrazeptivum
Beschreibung

Contraceptive

Datentyp

string

Alias
UMLS CUI
C0009871
SNOMED CT 2010_0731
417122000
Injektion
Beschreibung

Injection

Datentyp

string

Alias
UMLS CUI
C1533685
SNOMED CT 2010_0731
59108006
MedDRA 13.1
10052995
Intrauterine contraceptive device
Beschreibung

Intrauterine Devices

Datentyp

string

Alias
UMLS CUI
C0021900
SNOMED CT 2010_0731
268460000
MedDRA 13.1
10022745
Barrier contraception method
Beschreibung

Contraception, Barrier

Datentyp

string

Alias
UMLS CUI
C0004764
SNOMED CT 2010_0731
225370004
Double (qualifier value)
Beschreibung

Double

Datentyp

string

Alias
UMLS CUI
C0205173
SNOMED CT 2010_0731
1305003
Contraceptive Patch
Beschreibung

Contraceptive Patch

Datentyp

string

Alias
UMLS CUI
C2985284
Male sterilization (procedure)
Beschreibung

Male sterilization

Datentyp

string

Alias
UMLS CUI
C0024559
SNOMED CT 2010_0731
399141000
MedDRA 13.1
10065591
ICD-9-CM Version 2011
63.70
Entry
Beschreibung

Entry

Datentyp

string

Alias
UMLS CUI
C1705654
Studie
Beschreibung

Study

Datentyp

string

Alias
UMLS CUI
C0008976
SNOMED CT 2010_0731
110465008
Schwangerschaftstest (B-HCG im Serum)
Beschreibung

Serum pregnancy test

Datentyp

string

Alias
UMLS CUI
C0430060
SNOMED CT 2010_0731
166434005
negativer Schwangerschaftstest
Beschreibung

Negative Pregnancy Test

Datentyp

string

Alias
UMLS CUI
C0427780
SNOMED CT 2010_0731
250425007
MedDRA 13.1
10036574
Screening
Beschreibung

Screening

Datentyp

string

Alias
UMLS CUI
C1409616
Einverständniserklärung
Beschreibung

Informed Consent

Datentyp

string

Alias
UMLS CUI
C0021430
Pharmacogenomic Test
Beschreibung

Pharmacogenomic Test

Datentyp

string

Alias
UMLS CUI
C2347501
Procurement of patient informed consent, investigational study
Beschreibung

Procurement of patient informed consent, investigational study

Datentyp

string

Alias
UMLS CUI
C0021430
SNOMED CT 2010_0731
55149002
Subject Participation Status in Clinical Study
Beschreibung

Study Subject Participation Status

Datentyp

string

Alias
UMLS CUI
C2348568
Genetischer Test
Beschreibung

Genetic test

Datentyp

string

Alias
UMLS CUI
C0679560
SNOMED CT 2010_0731
405824009
Serum/plasma protein test
Beschreibung

Serum/plasma protein test

Datentyp

string

Alias
UMLS CUI
C0428486
SNOMED CT 2010_0731
166776003
Testing
Beschreibung

Testing

Datentyp

string

Alias
UMLS CUI
C0039593
Future
Beschreibung

Future

Datentyp

string

Alias
UMLS CUI
C0016884
Mandatory Testing
Beschreibung

Mandatory Testing

Datentyp

string

Alias
UMLS CUI
C0242803
Optional
Beschreibung

Optional

Datentyp

string

Alias
UMLS CUI
C1518600
Krebs
Beschreibung

Cancer

Datentyp

string

Alias
UMLS CUI
C0006826
SNOMED CT 2010_0731
363346000
MedDRA 13.1
10028997
LOINC Version 232
MTHU010328
ICD-10-CM Version 2010
C00-C96
Random Allocation
Beschreibung

Randomization

Datentyp

string

Alias
UMLS CUI
C0034656
Biochemischer Marker
Beschreibung

Biochemical Markers

Datentyp

string

Alias
UMLS CUI
C0206015
Marker, Biomarker
Beschreibung

Marker

Datentyp

string

Alias
UMLS CUI
C0005516
Radiographisch
Beschreibung

Radiographic

Datentyp

string

Alias
UMLS CUI
C0444708
SNOMED CT 2010_0731
258106000
Basalzellenkarzinom
Beschreibung

Basal cell carcinoma

Datentyp

string

Alias
UMLS CUI
C0007117
SNOMED CT 2010_0731
1338007
MedDRA 13.1
10004146
Plattenepithelkarzinom
Beschreibung

Squamous cell carcinoma

Datentyp

string

Alias
UMLS CUI
C0007137
SNOMED CT 2010_0731
28899001
MedDRA 13.1
10041823
In situ cancer
Beschreibung

In situ cancer

Datentyp

string

Alias
UMLS CUI
C0851135
MedDRA 13.1
10021570
klinisch
Beschreibung

Clinical

Datentyp

string

Alias
UMLS CUI
C0205210
SNOMED CT 2010_0731
58147004
Transformation
Beschreibung

Transformation

Datentyp

string

Alias
UMLS CUI
C1510411
Indolent Non-Hodgkin Lymphoma
Beschreibung

Indolent NHL

Datentyp

string

Alias
UMLS CUI
C1334170
Aggressive Non-Hodgkin Lymphoma
Beschreibung

Aggressive NHL

Datentyp

string

Alias
UMLS CUI
C0852469
MedDRA 13.1
10029608
Velcade
Beschreibung

Bortezomib

Datentyp

string

Alias
UMLS CUI
C1176309
SNOMED CT 2010_0731
407097007
Immunotherapy, antineoplastic
Beschreibung

antineoplastic Immunotherapy

Datentyp

string

Alias
UMLS CUI
C0864561
Antikörper
Beschreibung

Antibodies

Datentyp

string

Alias
UMLS CUI
C0003241
SNOMED CT 2010_0731
68498002
LOINC Version 232
MTHU003502
nicht konjugiert
Beschreibung

Unconjugated

Datentyp

string

Alias
UMLS CUI
C0522530
SNOMED CT 2010_0731
103396006
Antikörpertherapie
Beschreibung

Antibody Therapy

Datentyp

string

Alias
UMLS CUI
C0281176
HL7 V3 02-34
THER
Therapies, Investigational
Beschreibung

Experimental Therapies

Datentyp

string

Alias
UMLS CUI
C0949266
Radiotherapie, Strahlentherapie
Beschreibung

radiotherapy

Datentyp

string

Alias
UMLS CUI
C0034619
Nitroharnstoff
Beschreibung

Nitrosoureas

Datentyp

string

Alias
UMLS CUI
C0028210
SNOMED CT 2010_0731
372610009
Radioimmunoconjugate
Beschreibung

Radioimmunoconjugate

Datentyp

string

Alias
UMLS CUI
C0243019
Immunoconjugates
Beschreibung

Immunoconjugates

Datentyp

string

Alias
UMLS CUI
C0243020
Toxin
Beschreibung

Toxin

Datentyp

string

Alias
UMLS CUI
C0040549
SNOMED CT 2010_0731
80917008
stem cell transplantation
Beschreibung

Stem cell transplant

Datentyp

string

Alias
UMLS CUI
C1504389
MedDRA 13.1
10063581
operative procedures
Beschreibung

surgery

Datentyp

string

Alias
UMLS CUI
C0038895
Major (qualifier value)
Beschreibung

Major

Datentyp

string

Alias
UMLS CUI
C0205164
SNOMED CT 2010_0731
255603008
Residual
Beschreibung

Residual

Datentyp

string

Alias
UMLS CUI
C1609982
SNOMED CT 2010_0731
65320000
Toxisch
Beschreibung

Toxic

Datentyp

string

Alias
UMLS CUI
CL034921
poisonous effects
Beschreibung

poisonous effects

Datentyp

string

Alias
UMLS CUI
C0243147
Previous (qualifier value)
Beschreibung

Previous

Datentyp

string

Alias
UMLS CUI
C0205156
SNOMED CT 2010_0731
9130008
Grade 3
Beschreibung

Grade 3

Datentyp

string

Alias
UMLS CUI
C0450094
Disorders of the peripheral nervous system
Beschreibung

Peripheral Neuropathy

Datentyp

string

Alias
UMLS CUI
C0031117
MedDRA 13.1
10029331
ICD-10-CM Version 2010
G64
ICD-9-CM Version 2011
350-359.99
Neuropathic Pain
Beschreibung

Neuropathic Pain

Datentyp

string

Alias
UMLS CUI
CL428997
Grade 2
Beschreibung

Grade 2

Datentyp

string

Alias
UMLS CUI
C1522446
Investigational New Drug
Beschreibung

Investigational Drug

Datentyp

string

Alias
UMLS CUI
C0013230
Investigational Medical Device
Beschreibung

Investigational Device

Datentyp

string

Alias
UMLS CUI
C2346570
allergische Reaktion
Beschreibung

Allergic Reaction

Datentyp

string

Alias
UMLS CUI
C1527304
SNOMED CT 2010_0731
421668005
MedDRA 13.1
10001718
ICD-10-CM Version 2010
T78.40
Bor
Beschreibung

Boron

Datentyp

string

Alias
UMLS CUI
C0006030
SNOMED CT 2010_0731
70597009
LOINC Version 232
MTHU014128
Mannitol
Beschreibung

Mannitol

Datentyp

string

Alias
UMLS CUI
C0024730
SNOMED CT 2010_0731
387168006
LOINC Version 232
MTHU015736
Anaphylaxie, anaphylaktischer Schock
Beschreibung

anaphylaxis

Datentyp

string

Alias
UMLS CUI
C0002792
SNOMED CT 2010_0731
39579001
MedDRA 13.1
10002199
ICD-10-CM Version 2010
T78.2
CTCAE Version 4.03
E11254
IgE-mediated hypersensitivity disorder
Beschreibung

Immediate hypersensitivity

Datentyp

string

Alias
UMLS CUI
C0020523
SNOMED CT 2010_0731
422076005
MedDRA 13.1
10021413
Murine
Beschreibung

Mus

Datentyp

string

Alias
UMLS CUI
C0026809
SNOMED CT 2010_0731
447482001
Protein, Eiweiß
Beschreibung

Proteins

Datentyp

string

Alias
UMLS CUI
C0033684
SNOMED CT 2010_0731
88878007
LOINC Version 232
MTHU001951
Polyoxethylenesorbitan oleate
Beschreibung

Polysorbate 80

Datentyp

string

Alias
UMLS CUI
C0032601
SNOMED CT 2010_0731
255899003
sodium citrate dihydrate
Beschreibung

sodium citrate dihydrate

Datentyp

string

Alias
UMLS CUI
C0724696
kombinierte Therapie
Beschreibung

concurrent therapy

Datentyp

string

Alias
UMLS CUI
C0009429
Investigational New Drug, Experimental Drug
Beschreibung

Investigational Drug

Datentyp

string

Alias
UMLS CUI
C0013230
schwanger
Beschreibung

pregnant

Datentyp

string

Alias
UMLS CUI
C0549206
MedDRA 13.1
10036586
Stillzeit
Beschreibung

Lactation

Datentyp

string

Alias
UMLS CUI
C0006147
MedDRA 13.1
10006247

Ähnliche Modelle

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Einschlusskriterien
Age
Item
Alter >= 18 Jahre
boolean
follicular B-NHL, subtypes follicular lymphoma (FL) (Grades 1 and 2
Item
Diagnosis of follicular B-NHL of the following subtypes (World Health Organization [WHO] classification 1997): follicular lymphoma (FL) (Grades 1 and 2).
boolean
relapse or progression following prior anti-neoplastic treatment
Item
Documented relapse or progression following prior antineoplastic treatment. New lesions or objective evidence of progression of existing lesions must document relapse or progression following the previous therapy.
boolean
If any prior regimen included rituximab, the subject must have responded.
Item
If any prior regimen included rituximab, the subject must have responded (complete response [CR], unconfirmed complete response [CRu], partial response [PR]), and the time to progression (TTP) from the first dose of rituximab must have been 6 months or more.
boolean
At least 1 measurable tumor mass
Item
At least 1 measurable tumor mass (greater than 1.5 cm in the longest dimension and greater than 1.0 cm in the short axis) that has not been previously irradiated, or has grown since previous irradiation
boolean
the decision to initiate treatment is justified to manage the subject's lymphoma
Item
In the opinion of the investigator the decision to initiate treatment is justified to manage the subject's lymphoma
boolean
No active central nervous system lymphoma
Item
No active central nervous system lymphoma
boolean
ECOG status ? 2
Item
Eastern Cooperative Oncology Group [ECOG] status ? 2
boolean
Female subjects must be postmenopausal, surgically sterile, abstinent, or, if sexually active, be practicing an effective method of birth control; and have a negative pregnancy test at screening.
Item
Female subjects must be postmenopausal (for at least 6 months), surgically sterile, abstinent, or, if sexually active, be practicing an effective method of birth control (e.g., prescription oral contraceptives, contraceptive injections, intrauterine device, double-barrier method, contraceptive patch, male partner sterilization) before entry and throughout the study; and have a negative serum beta-human chorionic gonadotropin (?-hCG) pregnancy test at screening.
boolean
informed consent
Item
Subjects (or their legally acceptable representatives) must have signed an informed consent document indicating that they understand the purpose of and procedures required for the study and are willing to participate in the study.
boolean
If health authorities have approved the pharmacogenomic testing, subjects must have signed a separate informed consent.
Item
In countries where health authorities have approved the pharmacogenomic testing, subjects or their legally acceptable representatives must have signed a separate informed consent that they agree to participate in the genetic part and protein testing part of the study; participation in the genetic and protein testing component is mandatory for pharmacogenomics testing, but optional for serum protein testing and future testing.
boolean
Item Group
Ausschlusskriterien
malignancy other than NHL
Item
Diagnosed or treated for a malignancy other than NHL within 1 year of randomization, or who were previously diagnosed with a malignancy other than NHL and have any radiographic or biochemical marker evidence of malignancy. Subjects with completely resected basal cell carcinoma, squamous cell carcinoma of the skin, or in situ malignancy are not excluded.
boolean
transformation from indolent NHL to a more aggressive form of NHL
Item
Clinical evidence of a transformation from indolent NHL to a more aggressive form of NHL.
boolean
disallowed therapies
Item
Prior treatment with VELCADE; Antineoplastic (including unconjugated therapeutic antibodies), experimental, or radiation therapy within 3 weeks before randomization; Nitrosoureas within 6 weeks before randomization; Radioimmunoconjugates or toxin immunoconjugates within 10 weeks before randomization; Stem cell transplant within 6 months before randomization; Major surgery within 2 weeks before randomization.
boolean
Residual toxic effects of previous therapy or surgery
Item
Residual toxic effects of previous therapy or surgery of Grade 3 or worse
boolean
Peripheral neuropathy or neuropathic pain
Item
Peripheral neuropathy or neuropathic pain of Grade 2 or worse
boolean
Have received an experimental drug or used an experimental medical device.
Item
Have received an experimental drug or used an experimental medical device within 21 days before the planned start of treatment.
boolean
allergic reaction attributable to compounds containing boron or mannitol
Item
History of allergic reaction attributable to compounds containing boron or mannitol
boolean
hypersensitivity to murine proteins or to any component of rituximab
Item
Known anaphylaxis or immunoglobulin E (IgE)-mediated hypersensitivity to murine proteins or to any component of rituximab including polysorbate 80 and sodium citrate dihydrate
boolean
treatment with another investigational agent
Item
Concurrent treatment with another investigational agent
boolean
Female subject is pregnant or breast-feeding
Item
Female subject who is pregnant or breast-feeding
boolean
Item Group
Medizinische Konzepte
Age
Item
Alter
string
C0001779 (UMLS CUI)
397669002 (SNOMED CT 2010_0731)
Diagnosis
Item
Diagnose
string
C0011900 (UMLS CUI)
439401001 (SNOMED CT 2010_0731)
MTHU008876 (LOINC Version 232)
man
Item
Mann
string
C0025266 (UMLS CUI)
339947000 (SNOMED CT 2010_0731)
Woman
Item
Frau
string
C0043210 (UMLS CUI)
224526002 (SNOMED CT 2010_0731)
NHL
Item
Lymphoma, Non-Hodgkin (Non-Hodgkins lymphoma)
string
C0024305 (UMLS CUI)
118601006 (SNOMED CT 2010_0731)
10029547 (MedDRA 13.1)
C85.9 (ICD-10-CM Version 2010)
Lymphoma, Follicular
Item
Follicular low grade B-cell lymphoma, Follicular non-Hodgkin lymphoma
string
C0024301 (UMLS CUI)
277618009, 308121000 (SNOMED CT 2010_0731)
10061170 (MedDRA 13.1)
C82 (ICD-10-CM Version 2010)
202.0 (ICD-9-CM Version 2011)
FL grade I
Item
Follicular lymphoma grade I, unspecified site
string
C2853785 (UMLS CUI)
C82.00 (ICD-10-CM Version 2010)
FL grade II
Item
Follicular lymphoma grade II, unspecified site
string
C2853795 (UMLS CUI)
C82.10 (ICD-10-CM Version 2010)
WHO classification
Item
WHO-Klassifikation
string
C0451584 (UMLS CUI)
273931002 (SNOMED CT 2010_0731)
Relapse
Item
Rezidiv
string
C0277556 (UMLS CUI)
58184002 (SNOMED CT 2010_0731)
Documented
Item
Documented (qualifier value)
string
C1301725 (UMLS CUI)
397934002 (SNOMED CT 2010_0731)
Progression
Item
Krankheitsverlauf
string
C0242656 (UMLS CUI)
246453008 (SNOMED CT 2010_0731)
10061818 (MedDRA 13.1)
Antineoplastic Drug/Agent Therapy
Item
Antineoplastic Drug/Agent Therapy
string
CL378288 (UMLS CUI)
Therapy
Item
Therapie
string
C0087111 (UMLS CUI)
Previous
Item
Previous (qualifier value)
string
C0205156 (UMLS CUI)
9130008 (SNOMED CT 2010_0731)
Lesion
Item
Läsion
string
C0221198 (UMLS CUI)
49755003 (SNOMED CT 2010_0731)
Evidence
Item
Evidence of
string
C0332120 (UMLS CUI)
18669006 (SNOMED CT 2010_0731)
Regimen
Item
Treatment Regimen
string
CL031856 (UMLS CUI)
Rituxan
Item
Rituximab
string
C0732355 (UMLS CUI)
386919002 (SNOMED CT 2010_0731)
In complete remission
Item
Complete Response (CR)
string
C0677874 (UMLS CUI)
103338009 (SNOMED CT 2010_0731)
PR
Item
partial response (partial remission)
string
C1521726 (UMLS CUI)
103337004 (SNOMED CT 2010_0731)
TTP
Item
Time to Progression
string
CL425094 (UMLS CUI)
Mass
Item
Mass of body structure, Mass (morphologic abnormality), Tumor Mass
string
C0577559 (UMLS CUI)
4147007 (SNOMED CT 2010_0731)
10026865 (MedDRA 13.1)
Irradiation
Item
Irradiation
string
C1522449 (UMLS CUI)
108290001 (SNOMED CT 2010_0731)
10037794 (MedDRA 13.1)
Lymphoma
Item
Lymphom
string
C0024299 (UMLS CUI)
21964009 (SNOMED CT 2010_0731)
10025310 (MedDRA 13.1)
C85.9 (ICD-10-CM Version 2010)
CNS Lymphoma
Item
Central Nervous System Lymphoma
string
C0280803 (UMLS CUI)
307649006 (SNOMED CT 2010_0731)
10007953 (MedDRA 13.1)
200.5 (ICD-9-CM Version 2011)
Active
Item
aktiv
string
C0205177 (UMLS CUI)
55561003 (SNOMED CT 2010_0731)
ECOG
Item
ECOG Status
string
C1520224 (UMLS CUI)
424122007 (SNOMED CT 2010_0731)
female
Item
weiblich
string
C0086287 (UMLS CUI)
248152002 (SNOMED CT 2010_0731)
F (HL7 V3 02-34)
Postmenopause
Item
Postmenopause
string
C0206159 (UMLS CUI)
10051775 (MedDRA 13.1)
Surgical
Item
Operative Surgical Procedures
string
C0543467 (UMLS CUI)
83578000 (SNOMED CT 2010_0731)
10051332 (MedDRA 13.1)
MTHU000079 (LOINC Version 232)
Sterile
Item
Steril
string
C0232920 (UMLS CUI)
261029002 (SNOMED CT 2010_0731)
Abstinent
Item
Abstinent
string
C0457801 (UMLS CUI)
105542008 (SNOMED CT 2010_0731)
10043185 (MedDRA 13.1)
Contraception
Item
Kontrazeption
string
C0700589 (UMLS CUI)
146680009 (SNOMED CT 2010_0731)
10010808 (MedDRA 13.1)
Contraceptives, Oral
Item
orales Kontrazeptivum
string
C0009905 (UMLS CUI)
59261009 (SNOMED CT 2010_0731)
Prescriptions
Item
Prescription (procedure)
string
C0033080 (UMLS CUI)
16076005 (SNOMED CT 2010_0731)
Contraceptive
Item
Kontrazeptivum
string
C0009871 (UMLS CUI)
417122000 (SNOMED CT 2010_0731)
Injection
Item
Injektion
string
C1533685 (UMLS CUI)
59108006 (SNOMED CT 2010_0731)
10052995 (MedDRA 13.1)
Intrauterine Devices
Item
Intrauterine contraceptive device
string
C0021900 (UMLS CUI)
268460000 (SNOMED CT 2010_0731)
10022745 (MedDRA 13.1)
Contraception, Barrier
Item
Barrier contraception method
string
C0004764 (UMLS CUI)
225370004 (SNOMED CT 2010_0731)
Double
Item
Double (qualifier value)
string
C0205173 (UMLS CUI)
1305003 (SNOMED CT 2010_0731)
Contraceptive Patch
Item
Contraceptive Patch
string
C2985284 (UMLS CUI)
Male sterilization
Item
Male sterilization (procedure)
string
C0024559 (UMLS CUI)
399141000 (SNOMED CT 2010_0731)
10065591 (MedDRA 13.1)
63.70 (ICD-9-CM Version 2011)
Entry
Item
Entry
string
C1705654 (UMLS CUI)
Study
Item
Studie
string
C0008976 (UMLS CUI)
110465008 (SNOMED CT 2010_0731)
Serum pregnancy test
Item
Schwangerschaftstest (B-HCG im Serum)
string
C0430060 (UMLS CUI)
166434005 (SNOMED CT 2010_0731)
Negative Pregnancy Test
Item
negativer Schwangerschaftstest
string
C0427780 (UMLS CUI)
250425007 (SNOMED CT 2010_0731)
10036574 (MedDRA 13.1)
Screening
Item
Screening
string
C1409616 (UMLS CUI)
Informed Consent
Item
Einverständniserklärung
string
C0021430 (UMLS CUI)
Pharmacogenomic Test
Item
Pharmacogenomic Test
string
C2347501 (UMLS CUI)
Procurement of patient informed consent, investigational study
Item
Procurement of patient informed consent, investigational study
string
C0021430 (UMLS CUI)
55149002 (SNOMED CT 2010_0731)
Study Subject Participation Status
Item
Subject Participation Status in Clinical Study
string
C2348568 (UMLS CUI)
Genetic test
Item
Genetischer Test
string
C0679560 (UMLS CUI)
405824009 (SNOMED CT 2010_0731)
Serum/plasma protein test
Item
Serum/plasma protein test
string
C0428486 (UMLS CUI)
166776003 (SNOMED CT 2010_0731)
Testing
Item
Testing
string
C0039593 (UMLS CUI)
Future
Item
Future
string
C0016884 (UMLS CUI)
Mandatory Testing
Item
Mandatory Testing
string
C0242803 (UMLS CUI)
Optional
Item
Optional
string
C1518600 (UMLS CUI)
Cancer
Item
Krebs
string
C0006826 (UMLS CUI)
363346000 (SNOMED CT 2010_0731)
10028997 (MedDRA 13.1)
MTHU010328 (LOINC Version 232)
C00-C96 (ICD-10-CM Version 2010)
Randomization
Item
Random Allocation
string
C0034656 (UMLS CUI)
Biochemical Markers
Item
Biochemischer Marker
string
C0206015 (UMLS CUI)
Marker
Item
Marker, Biomarker
string
C0005516 (UMLS CUI)
Radiographic
Item
Radiographisch
string
C0444708 (UMLS CUI)
258106000 (SNOMED CT 2010_0731)
Basal cell carcinoma
Item
Basalzellenkarzinom
string
C0007117 (UMLS CUI)
1338007 (SNOMED CT 2010_0731)
10004146 (MedDRA 13.1)
Squamous cell carcinoma
Item
Plattenepithelkarzinom
string
C0007137 (UMLS CUI)
28899001 (SNOMED CT 2010_0731)
10041823 (MedDRA 13.1)
In situ cancer
Item
In situ cancer
string
C0851135 (UMLS CUI)
10021570 (MedDRA 13.1)
Clinical
Item
klinisch
string
C0205210 (UMLS CUI)
58147004 (SNOMED CT 2010_0731)
Transformation
Item
Transformation
string
C1510411 (UMLS CUI)
Indolent NHL
Item
Indolent Non-Hodgkin Lymphoma
string
C1334170 (UMLS CUI)
Aggressive NHL
Item
Aggressive Non-Hodgkin Lymphoma
string
C0852469 (UMLS CUI)
10029608 (MedDRA 13.1)
Bortezomib
Item
Velcade
string
C1176309 (UMLS CUI)
407097007 (SNOMED CT 2010_0731)
antineoplastic Immunotherapy
Item
Immunotherapy, antineoplastic
string
C0864561 (UMLS CUI)
Antibodies
Item
Antikörper
string
C0003241 (UMLS CUI)
68498002 (SNOMED CT 2010_0731)
MTHU003502 (LOINC Version 232)
Unconjugated
Item
nicht konjugiert
string
C0522530 (UMLS CUI)
103396006 (SNOMED CT 2010_0731)
Antibody Therapy
Item
Antikörpertherapie
string
C0281176 (UMLS CUI)
THER (HL7 V3 02-34)
Experimental Therapies
Item
Therapies, Investigational
string
C0949266 (UMLS CUI)
radiotherapy
Item
Radiotherapie, Strahlentherapie
string
C0034619 (UMLS CUI)
Nitrosoureas
Item
Nitroharnstoff
string
C0028210 (UMLS CUI)
372610009 (SNOMED CT 2010_0731)
Radioimmunoconjugate
Item
Radioimmunoconjugate
string
C0243019 (UMLS CUI)
Immunoconjugates
Item
Immunoconjugates
string
C0243020 (UMLS CUI)
Toxin
Item
Toxin
string
C0040549 (UMLS CUI)
80917008 (SNOMED CT 2010_0731)
Stem cell transplant
Item
stem cell transplantation
string
C1504389 (UMLS CUI)
10063581 (MedDRA 13.1)
surgery
Item
operative procedures
string
C0038895 (UMLS CUI)
Major
Item
Major (qualifier value)
string
C0205164 (UMLS CUI)
255603008 (SNOMED CT 2010_0731)
Residual
Item
Residual
string
C1609982 (UMLS CUI)
65320000 (SNOMED CT 2010_0731)
Toxic
Item
Toxisch
string
CL034921 (UMLS CUI)
poisonous effects
Item
poisonous effects
string
C0243147 (UMLS CUI)
Previous
Item
Previous (qualifier value)
string
C0205156 (UMLS CUI)
9130008 (SNOMED CT 2010_0731)
Grade 3
Item
Grade 3
string
C0450094 (UMLS CUI)
Peripheral Neuropathy
Item
Disorders of the peripheral nervous system
string
C0031117 (UMLS CUI)
10029331 (MedDRA 13.1)
G64 (ICD-10-CM Version 2010)
350-359.99 (ICD-9-CM Version 2011)
Neuropathic Pain
Item
Neuropathic Pain
string
CL428997 (UMLS CUI)
Grade 2
Item
Grade 2
string
C1522446 (UMLS CUI)
Investigational Drug
Item
Investigational New Drug
string
C0013230 (UMLS CUI)
Investigational Device
Item
Investigational Medical Device
string
C2346570 (UMLS CUI)
Allergic Reaction
Item
allergische Reaktion
string
C1527304 (UMLS CUI)
421668005 (SNOMED CT 2010_0731)
10001718 (MedDRA 13.1)
T78.40 (ICD-10-CM Version 2010)
Boron
Item
Bor
string
C0006030 (UMLS CUI)
70597009 (SNOMED CT 2010_0731)
MTHU014128 (LOINC Version 232)
Mannitol
Item
Mannitol
string
C0024730 (UMLS CUI)
387168006 (SNOMED CT 2010_0731)
MTHU015736 (LOINC Version 232)
anaphylaxis
Item
Anaphylaxie, anaphylaktischer Schock
string
C0002792 (UMLS CUI)
39579001 (SNOMED CT 2010_0731)
10002199 (MedDRA 13.1)
T78.2 (ICD-10-CM Version 2010)
E11254 (CTCAE Version 4.03)
Immediate hypersensitivity
Item
IgE-mediated hypersensitivity disorder
string
C0020523 (UMLS CUI)
422076005 (SNOMED CT 2010_0731)
10021413 (MedDRA 13.1)
Mus
Item
Murine
string
C0026809 (UMLS CUI)
447482001 (SNOMED CT 2010_0731)
Proteins
Item
Protein, Eiweiß
string
C0033684 (UMLS CUI)
88878007 (SNOMED CT 2010_0731)
MTHU001951 (LOINC Version 232)
Polysorbate 80
Item
Polyoxethylenesorbitan oleate
string
C0032601 (UMLS CUI)
255899003 (SNOMED CT 2010_0731)
sodium citrate dihydrate
Item
sodium citrate dihydrate
string
C0724696 (UMLS CUI)
concurrent therapy
Item
kombinierte Therapie
string
C0009429 (UMLS CUI)
Investigational Drug
Item
Investigational New Drug, Experimental Drug
string
C0013230 (UMLS CUI)
pregnant
Item
schwanger
string
C0549206 (UMLS CUI)
10036586 (MedDRA 13.1)
Lactation
Item
Stillzeit
string
C0006147 (UMLS CUI)
10006247 (MedDRA 13.1)

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video